CME Group (NASDAQ:CME) Director Sells $91,770.00 in Stock

CME Group Inc. (NASDAQ:CME) Director Martin Gepsman sold 300 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $305.90, for a total transaction of $91,770.00. Following the transaction, the director owned 24,999 shares in the company, valued at approximately $7,647,194.10. The trade was a 1.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

CME Group Price Performance

CME Group stock opened at $308.09 on Monday. The firm has a market capitalization of $111.10 billion, a P/E ratio of 27.61, a PEG ratio of 3.60 and a beta of 0.27. CME Group Inc. has a 1 year low of $246.91 and a 1 year high of $309.35. The business has a 50-day moving average of $283.19 and a 200-day moving average of $274.74. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, beating analysts’ consensus estimates of $2.75 by $0.02. CME Group had a net margin of 62.45% and a return on equity of 14.65%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the prior year, the company earned $2.52 EPS. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be given a $1.30 dividend. This is a boost from CME Group’s previous quarterly dividend of $1.25. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s payout ratio is presently 44.80%.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME’s formal announcement to offer 24/7 trading for crypto futures and options — a move that addresses the timing gap with always‑on spot crypto markets and could lift ADV and fee revenue; the company cited record crypto notional volume in 2025. CME Group to Launch 24/7 Cryptocurrency Futures and Options Trading on May 29
• Positive Sentiment: Widespread coverage emphasizes the practical impacts — continuous trading can reduce “CME gaps,” boost institutional flow and expand crypto derivatives ADV, supporting the bullish thesis for trading‑fee growth. CME targets May launch for 24/7 crypto derivatives trading
• Positive Sentiment: Analyst/fin‑media bullishness — some outlets include CME among top picks, arguing the firm converts market volatility into trading revenue, which supports the stock’s rally. 2 Best Stocks to Buy Right Now for February
• Neutral Sentiment: Macro/market context — broader market moves (small‑cap rotation and sector flows) could be influencing intraday moves in financials/exchanges but are not specific to CME’s fundamentals. Small Caps Stage Quiet Comeback As AI Trade Shows Cracks
• Neutral Sentiment: Reported short‑interest data appears immaterial or inconsistent (no meaningful change reported); it isn’t currently signaling a large positioning risk.
• Negative Sentiment: Insider selling — director Martin J. Gepsman sold 300 shares; small in size but noteworthy as a disclosed insider sale. Insider Sale: Martin J. Gepsman
• Negative Sentiment: Critical takeaways — at least one outlet warns of risks to the CME thesis (valuation and competitive/operational risks), which could temper enthusiasm if amplified by further negative coverage. 2 Reasons CME is Risky and 1 Stock to Buy Instead

Analysts Set New Price Targets

Several analysts recently issued reports on the company. Raymond James Financial dropped their target price on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. Bank of America upped their price objective on CME Group from $201.00 to $209.00 in a research note on Wednesday, December 10th. Weiss Ratings reissued a “buy (b+)” rating on shares of CME Group in a report on Monday, December 29th. UBS Group restated a “neutral” rating and set a $310.00 target price on shares of CME Group in a report on Friday, February 6th. Finally, TD Cowen upped their price target on shares of CME Group from $305.00 to $328.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $299.53.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in CME. Caldwell Trust Co raised its stake in CME Group by 116.3% in the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Asset Dedication LLC increased its holdings in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group in the 3rd quarter valued at approximately $27,000. FNY Investment Advisers LLC bought a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Institutional investors own 87.75% of the company’s stock.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.